​

Cardinal Health (CAH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CAH Stock Forecast

Cardinal Health (CAH) stock forecast, based on 33 Wall Street analysts, predicts a 12-month average price target of $252.33, with a high of $275.00 and a low of $220.00. This represents a 17.13% increase from the last price of $215.42.

$50 $100 $150 $200 $250 $300 High: $275 Avg: $252.33 Low: $220 Last Closed Price: $215.42

CAH Stock Rating

Cardinal Health stock's rating consensus is Buy, based on 33 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 18 Buy (54.55%), 15 Hold (45.45%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 33 0 15 18 Strong Sell Sell Hold Buy Strong Buy

CAH Price Target Upside V Benchmarks

TypeNameUpside
StockCardinal Health17.13%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks12.90%

Price Target Trends

1M3M12M
# Anlaysts21223
Avg Price Target$266.50$250.67$227.74
Last Closing Price$215.42$215.42$215.42
Upside/Downside23.71%16.36%5.72%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 262114--17
Feb, 262113-117
Jan, 262104-117
Dec, 251104-116
Nov, 251104-116
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 09, 2026Michael ChernyLeerink Partners$275.00$222.2823.72%27.66%
Feb 24, 2026Barclays$258.00$224.8214.76%19.77%
Feb 10, 2026Wells Fargo$256.00$225.7613.39%18.84%
Feb 06, 2026Morgan Stanley$255.00$229.6311.05%18.37%
Feb 06, 2026Robert W. Baird$252.00$228.7810.15%16.98%
Feb 06, 2026Kevin CaliendoUBS$260.00$228.6313.72%20.69%
Feb 06, 2026Steven ValiquetteMizuho Securities$235.00$227.183.44%9.09%
Feb 05, 2026Elizabeth AndersonEvercore ISI$260.00$227.1814.45%20.69%
Jan 29, 2026Erin WrightMorgan Stanley$245.00$210.3916.45%13.73%
Jan 14, 2026Eric ColdwellRobert W. Baird$250.00$211.9817.94%16.05%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 09, 2026Leerink PartnersOutperformOutperformhold
Feb 24, 2026BarclaysOverweightOverweighthold
Feb 10, 2026Wells FargoOverweightOverweighthold
Feb 06, 2026UBSBuyBuyhold
Feb 05, 2026Evercore ISIOutperformOutperformhold
Jan 29, 2026Morgan StanleyOverweightOverweighthold
Jan 27, 2026Cowen & Co.BuyBuyhold
Jan 09, 2026CitigroupNeutralBuyupgrade
Dec 08, 2025BarclaysOverweightOverweightinitialise
Nov 03, 2025JefferiesBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-1 $3 $7 $11 $15 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$2.09$-3.34$1.26$3.48$6.48----
Avg Forecast$5.99$5.19$5.74$7.36$7.87$8.76$9.68$10.78$12.76
High Forecast$6.19$5.36$5.87$7.37$7.92$8.95$10.83$11.02$13.05
Low Forecast$5.86$5.07$5.63$7.34$7.78$8.45$7.95$10.56$12.50
Surprise %-65.11%-164.35%-78.05%-52.72%-17.66%----

Revenue Forecast

$150B $190B $230B $270B $310B $350B Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$162.47B$181.36B$205.01B$226.83B$222.58B----
Avg Forecast$160.21B$178.77B$204.30B$225.71B$221.21B$239.25B$256.89B$275.37B$322.52B
High Forecast$164.32B$183.35B$207.84B$226.11B$223.15B$241.57B$257.33B$280.14B$328.11B
Low Forecast$157.40B$175.63B$201.12B$225.39B$219.46B$236.65B$256.45B$271.08B$317.50B
Surprise %1.41%1.45%0.35%0.50%0.62%----

Net Income Forecast

$-1B $-100M $800M $2B $3B $4B Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$611.00M$-933.00M$330.00M$852.00M$1.56B----
Avg Forecast$1.20B$601.41M$1.42B$1.28B$1.94B$2.15B$2.32B$2.66B$3.15B
High Forecast$1.51B$721.69M$1.45B$1.83B$1.96B$2.21B$2.67B$2.72B$3.22B
Low Forecast$896.01M$481.12M$1.39B$734.28M$1.92B$2.09B$1.96B$2.61B$3.09B
Surprise %-49.25%-255.14%-76.74%-33.44%-19.45%----

CAH Forecast FAQ

Is Cardinal Health stock a buy?

Cardinal Health stock has a consensus rating of Buy, based on 33 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 18 Buy, 15 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cardinal Health is a favorable investment for most analysts.

What is Cardinal Health's price target?

Cardinal Health's price target, set by 33 Wall Street analysts, averages $252.33 over the next 12 months. The price target range spans from $220 at the low end to $275 at the high end, suggesting a potential 17.13% change from the previous closing price of $215.42.

How does Cardinal Health stock forecast compare to its benchmarks?

Cardinal Health's stock forecast shows a 17.13% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical distribution stocks industry (12.90%).

What is the breakdown of analyst ratings for Cardinal Health over the past three months?

  • March 2026: 11.76% Strong Buy, 64.71% Buy, 23.53% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 11.76% Strong Buy, 64.71% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.
  • January 2026: 11.76% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 5.88% Strong Sell.

What is Cardinal Health’s EPS forecast?

Cardinal Health's average annual EPS forecast for its fiscal year ending in June 2026 is $8.76, marking a 35.19% increase from the reported $6.48 in 2025. Estimates for the following years are $9.68 in 2027, $10.78 in 2028, and $12.76 in 2029.

What is Cardinal Health’s revenue forecast?

Cardinal Health's average annual revenue forecast for its fiscal year ending in June 2026 is $239.25B, reflecting a 7.49% increase from the reported $222.58B in 2025. The forecast for 2027 is $256.89B, followed by $275.37B for 2028, and $322.52B for 2029.

What is Cardinal Health’s net income forecast?

Cardinal Health's net income forecast for the fiscal year ending in June 2026 stands at $2.15B, representing an 37.67% increase from the reported $1.56B in 2025. Projections indicate $2.32B in 2027, $2.66B in 2028, and $3.15B in 2029.